Application of eIF4E-1 factor amino acid mutation in relieving sensitivity of anti-PVY virus tobacco mutant to cold injury stress

By introducing specific amino acid mutations into the eIF4E-1 factor of tobacco, the problem of anti-PVY virus tobacco mutants is solved, and the effect of improving tobacco's resistance to PVY virus is achieved.

CN118910134APending Publication Date: 2024-11-08YUNNAN ACAD OF TOBACCO AGRI SCI
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411128972.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-09-04
Filing Date
2024-08-16
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing tobacco mutants that are anti-PVY viruses are sensitive to cold damage stress, affecting yield and quality, and existing mutation methods may lead to plants being more sensitive to cold damage stress.

Method used

By introducing specific amino acid mutations in the eIF4E-1 factor, such as replacement or deletion of amino acids at positions 97 and 99, such as Val replaced by Gln, Ala replaced by Glu, to obtain resistance to PVY virus while not being cold-hardened. Sensitive tobacco mutants.

Benefits of technology

It has achieved the reduction of sensitivity to cold damage stress without affecting the plant's resistance to PVY virus, and improved the disease resistance and cold resistance of tobacco.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910134A_ABST
    Figure CN118910134A_ABST
Patent Text Reader

Abstract

The invention relates to application of eIF4E-1 factor amino acid mutation in relieving sensitivity of PVY virus resistant tobacco mutants to cold injury stress, and belongs to the technical field of molecular biology. The invention provides application of 97th-100th amino acid mutation of an eIF4E-1 factor in relieving sensitivity of an anti-PVY virus tobacco mutant to cold injury stress, and provides a protein, a gene and a method for relieving sensitivity of the anti-PVY virus tobacco mutant to cold injury stress. Compared with a tobacco mutant material with PVY resistance reported in the prior art, the tobacco mutant material obtained by the invention can generate PVY resistance or even has better PVY resistance, and under the same cold injury stress condition, the tobacco mutant material disclosed by the invention is insensitive to cold injury stress, and can be used for preparing the tobacco mutant material. However, the tobacco mutant material with PVY resistance reported in the prior art is sensitive to cold injury stress.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of molecular biology, and specifically relates to the use of amino acid mutation of eIF4E-1 factor in alleviating the sensitivity of PVY virus-resistant tobacco mutants to chilling stress. Background Art

[0002] Tobacco is the most important cash crop in Yunnan Province, but tobacco suffers from pests and diseases during production, which greatly affects the quality and economic value of tobacco leaves. The most representative one is the genus Potato virus Y, which can usually cause huge losses to tobacco production. Among them, Potato virus Y (PVY) belongs to the Potato virus family (Potyviridae) and Potyvirus genus (Potyvirus). PVY virus was discovered in 1931 because it seriously affected potato production. The virus mainly infects Solanaceae plants, such as potatoes, tobacco, tomatoes and peppers. PVY is a positive single-stranded RNA virus. The virus particles are curved and linear, with a diameter of about 11-12 nanometers and a length of about 730-740 nanometers. After tobacco leaves are infected by PVY virus, the growth rate of tobacco slows down significantly, the plants become dwarfed, the number of leaves decreases, and the leaf area decreases, resulting in a serious impact on the growth of the entire plant. When the infection is serious, the color and flavor of the flue-cured tobacco will deteriorate, the quality will be significantly reduced, and the nicotine content will decrease and the total nitrogen content will increase, causing the tobacco leaves to lose their economic value, bringing great losses to tobacco farmers and tobacco companies. For the prevention and control of PVY, the effect of chemical pesticides is limited, and it may cause secondary damage to the plants. Therefore, the cultivation of PVY-resistant varieties is the key to solving the problem of tobacco infected with PVY virus. The antigen currently widely used in tobacco is the PVY antigen discovered by G. Koellent between 1961 and 1964. The antigen is a variant of the cultivated variety VirginA, VirginAMutant (TI1406). Subsequent studies have shown that the mutant variety lacks the eIF4E-1 gene, which encodes a gene in the eukaryotic translation initiation factor (eIF). At present, some mainstream tobacco varieties resistant to PVY virus, such as NC745, TN86 and TN90, use this mutation site. Because this site lacks a large fragment, it will have an adverse effect on the growth and development of tobacco. There are also reports on knocking out the eIF4E-1 gene in tobacco using EMS technology or gene editing technology. When only the eIF4E-1 gene is knocked out, tobacco can also produce resistance to PVY virus, but simple mutation of the eIF4E-1 gene will make the plant more sensitive to cold stress, which will affect the yield and quality of the plant. Therefore, it is necessary to create tobacco materials with eIF4E-1 gene mutants that are insensitive to cold stress. Summary of the invention

[0003] In order to solve the problem of the existing eIF4E-1 tobacco mutants being sensitive to chilling stress in the prior art and to meet the need for developing new eIF4E-1 tobacco mutants that are insensitive to chilling stress, the present invention provides a tobacco curly stem virus RT-LAMP detection primer, a kit and its application and method.

[0004] The technical contents of the present invention are as follows:

[0005] The use of amino acid mutations at positions 97-100 of the eIF4E-1 factor in alleviating the sensitivity of PVY virus-resistant tobacco mutants to cold stress.

[0006] The amino acid mutation at positions 97-100 of the eIF4E-1 factor is selected from: deletion of amino acids at positions 97-100 of the eIF4E-1 factor, and / or substitution of amino acids at positions 97 and 99 of the eIF4E-1 factor;

[0007] Preferably, the amino acid substitutions at positions 97 and 99 refer to: the amino acid Val at position 97 is substituted with Gln, and the amino acid Ala at position 99 is substituted with Glu;

[0008] Preferably, the PVY virus-resistant tobacco mutant refers to tobacco material with eIF4E-1 gene mutation;

[0009] Preferably, the eIF4E-1 gene mutations include: eIF4E-1 gene position 289 G mutation to C, eIF4E-1 gene position 290 T mutation to A, eIF4E-1 gene position 297 C mutation to A;

[0010] Preferably, the chilling stress refers to chilling stress below 8°C.

[0011] A protein that alleviates the sensitivity of a PVY virus-resistant tobacco mutant to cold stress, characterized in that it is a protein obtained by mutation of amino acids at positions 97-100 of the eIF4E-1 factor.

[0012] The protein with amino acid mutations at positions 97-100 of the eIF4E-1 factor is selected from: a protein with amino acids at positions 97-100 deleted from the eIF4E-1 factor, and / or a protein with amino acids at positions 97 and 99 replaced from the eIF4E-1 factor;

[0013] Preferably, the protein in which the amino acids at positions 97 and 99 of the eIF4E-1 factor are replaced refers to a protein in which the amino acid at position 97 Val is replaced by Gln, and the amino acid at position 99 Ala is replaced by Glu;

[0014] Preferably, the protein with amino acids 97-100 deleted from eIF4E-1 factor has the amino acid sequence shown in SEQ ID NO.1;

[0015] Preferably, the protein with amino acids 97 and 99 substituted in the eIF4E-1 factor has the amino acid sequence shown in SEQ ID NO.2.

[0016] A gene that alleviates the sensitivity of a PVY virus-resistant tobacco mutant to cold stress, characterized in that it is a gene obtained by mutation of bases 289-300 of the eIF4E-1 gene.

[0017] The gene obtained by mutation of bases 289-300 of the eIF4E-1 gene is selected from: a gene obtained by deletion of bases 289-300 of the eIF4E-1 gene, and / or a gene obtained by substitution mutation of bases 289-291 and 295-297 of the eIF4E-1 gene;

[0018] Preferably, the gene obtained by base substitution mutations at positions 289-291 and 295-297 of the eIF4E-1 gene refers to a gene obtained by mutation of G at position 289 to C, mutation of T at position 290 to A, and mutation of C at position 297 to A of the eIF4E-1 gene;

[0019] Preferably, the gene obtained by mutation of bases 289-300 of the eIF4E-1 gene has a nucleotide sequence as shown in SEQ ID NO.3;

[0020] Preferably, the gene obtained by base substitution mutation at positions 289-291 and 295-297 of the eIF4E-1 gene has a nucleotide sequence as shown in SEQ ID NO.4.

[0021] A method for alleviating the sensitivity of PVY virus-resistant tobacco mutants to chilling stress, characterized in that the amino acids at positions 97-100 of the eIF4E-1 factor of wild-type tobacco materials are mutated or the bases at positions 289-300 of the eIF4E-1 gene of wild-type tobacco materials are mutated.

[0022] The mutation of amino acids 97-100 of the eIF4E-1 factor of the wild-type tobacco material is selected from: deleting amino acids 97-100 of the eIF4E-1 factor of the wild-type tobacco material, and / or replacing amino acids 97 and 99 of the eIF4E-1 factor of the wild-type tobacco material;

[0023] The mutation of bases 289-300 of the eIF4E-1 gene of the wild-type tobacco material is selected from: deleting bases 289-300 of the eIF4E-1 gene of the wild-type tobacco material, and / or replacing bases 289-291 and 295-297 of the eIF4E-1 gene of the wild-type tobacco material;

[0024] Preferably, the epegRNA sequence in which the amino acids 97-100 of the eIF4E-1 factor of the wild-type tobacco material are deleted or the bases 289-300 of the eIF4E-1 gene of the wild-type tobacco material are deleted is as shown in SEQ ID NO.5;

[0025] Preferably, the epegRNA sequence in which the amino acids 97 and 99 of the eIF4E-1 factor of the wild-type tobacco material are replaced or the bases 289-291 and 295-297 of the eIF4E-1 gene of the wild-type tobacco material are replaced is as shown in SEQ ID NO.6.

[0026] A method for obtaining and screening tobacco mutants that are resistant to PVY and insensitive to chilling stress, characterized in that a method for alleviating the sensitivity of PVY virus-resistant tobacco mutants to chilling stress is used to obtain tobacco mutants that are resistant to PVY and insensitive to chilling stress.

[0027] The screening refers to: using VGAD-F3 and VGAD-R3 primers to amplify and sequence DNA of candidate tobacco materials.

[0028] The present invention achieves tobacco resistance to PVY virus without causing eIF4E-1 gene frameshift or premature termination of expression. The present invention is applied in plant breeding and can be used to cultivate plants, especially crops, that are resistant to PVY virus. A method for applying these point mutations in tobacco is also developed.

[0029] Technical solution: In order to solve the above technical problems, the technical solution adopted by the present invention is as follows: The present invention provides a protein that makes plants resistant to PVY virus, and knocks out the amino acids at positions 97 and 99. There is currently no report that replacing the amino acids at positions 97 and 99 of the protein encoded by the tobacco eIF4E-1 gene will make tobacco resistant to PVY virus.

[0030] In addition to the mutant plant screening or amplification methods described in the embodiments of the present invention, the eIF4E-1 protein with 97th and 99th amino acid substitutions provided in some experimental examples of the present invention, when the protein sequence is known, those skilled in the art are capable of preparing proteins with substituted, added or deleted amino acid residues by changing the coding gene sequence of the known protein and introducing it into a vector, and these methods are all conventional means. In a specific embodiment of the present invention, the amino acid sequence of the protein with anti-PVY virus resistance of the present invention is shown in SEQ ID NO:2.

[0031] Other experimental examples of the present invention provide nucleic acids encoding the above-mentioned eIF4E-1 protein of the present invention. In the present invention, the nucleic acid can be DNA, RNA, and preferably cDNA. On the premise of knowing the encoded protein sequence or nucleic acid sequence, through conventional codon correspondence and host expression frequency, using PCR methods, cDNA recombination methods or artificial synthesis methods, those skilled in the art are capable of obtaining and optimizing the nucleic acid encoding the protein of the first aspect of the present invention. Once the nucleic acid is obtained, it can be cloned into a vector, transformed or transfected into the corresponding cells, and then proliferated by conventional host cells to isolate a large amount of nucleic acid. Preferably, the nucleotide sequence of the nucleic acid of the second aspect of the present invention is shown in SEQ ID NO: 1. Specifically, the cDNA sequence of the present invention is a base substitution at the 287th, 288th and 294th nucleotides of the wild-type tobacco Yunyan 87.

[0032] The present invention provides an eIF4E-1 protein that makes plants resistant to PVY virus, and knocks out the amino acids at positions 97-100. Currently, there is no report that knocking out the amino acids at positions 97-100 of the protein encoded by the tobacco eIF4E-1 gene will make tobacco resistant to PVY virus.

[0033] Some experimental examples of the present invention provide eIF4E-1 proteins with amino acid deletions at positions 97-100. In addition to the mutant plant screening or amplification methods described in the embodiments of the present invention, when the protein sequence is known, those skilled in the art are capable of preparing proteins with substituted, added or deleted amino acid residues by changing the coding gene sequence of the known protein and introducing it into a vector. These methods are all conventional means. In a specific embodiment of the present invention, the amino acid sequence of the protein having anti-PVY virus resistance of the present invention is shown in SEQ ID NO: 2.

[0034] Some other experimental examples of the present invention provide nucleic acids encoding the above-mentioned eIF4E-1 protein of the present invention. In the present invention, the nucleic acid can be DNA, RNA, preferably DNA. On the premise of knowing the encoded protein sequence or nucleic acid sequence, through conventional codon correspondence and host expression frequency, using PCR methods, DNA recombination methods or artificial synthesis methods, those skilled in the art are able to obtain and optimize the nucleic acid encoding the protein of the first aspect of the present invention. Once the nucleic acid is obtained, it can be cloned into a vector, transformed or transfected into the corresponding cells, and then proliferated by conventional host cells to isolate a large amount of nucleic acid. Preferably, the nucleotide sequence of the nucleic acid of the second aspect of the present invention is shown in SEQ ID NO: 1. Specifically, the DNA sequence of the present invention is a deletion of nucleotides 287-300 of the wild-type tobacco Yunyan 87.

[0035] Some experimental examples of the present invention also provide a method for obtaining a plant resistant to PVY virus, comprising the following steps:

[0036] 1) making the plant contain the nucleic acid of the present invention; or

[0037] 2) allowing the plant to express the protein.

[0038] Wherein, the above method includes the steps of genetic modification, hybridization, backcrossing or asexual reproduction.

[0039] The beneficial effects of the present invention are as follows:

[0040] The present invention finds that the tobacco mutant material obtained by mutating the 97th to 100th amino acids of the tobacco eIF4E-1 factor can obtain significant PVY virus resistance and not produce the defect of sensitivity to cold damage stress. The present invention shows that the tobacco eIF4E-1 gene encoding protein exhibits significant PVY resistance after the deletion of 4 amino acids through the results of inoculating the mutant strain with PVY virus. Compared with the tobacco mutant materials with PVY resistance reported in the prior art, the tobacco mutant materials obtained by the present invention will produce PVY resistance or even better PVY resistance, and under the same cold damage stress conditions, the tobacco mutant materials of the present invention are not sensitive to cold damage stress, while the tobacco mutant materials with PVY resistance reported in the prior art are sensitive to cold damage stress. BRIEF DESCRIPTION OF THE DRAWINGS

[0041] Figure 1 Schematic diagram of the structure of the DiPE2 carrier of Experimental Example 1 of the present invention.

[0042] Figure 2 Electrophoresis of PCR fragments of tobacco mutant materials with amino acid substitutions at positions 97 and 99 obtained by prime editing technology.

[0043] Figure 3 Electrophoresis of PCR fragments of tobacco mutant materials with amino acid deletions at positions 97-100 obtained by prime editing technology.

[0044] Figure 4 This is the heterozygous site sequencing map of the tobacco mutant T0 generation material with amino acid substitutions at positions 97 and 99 obtained by the lead editing technology in Experimental Example 2 of the present invention.

[0045] Figure 5 This is the homozygous site sequencing map of the tobacco mutant T1 generation material with amino acid substitutions at positions 97 and 99 obtained by the lead editing technology in Experimental Example 2 of the present invention.

[0046] Figure 6 This is the heterozygous site sequencing map of the tobacco mutant T0 generation material with amino acids 97-100 deleted obtained by the lead editing technology in Experimental Example 2 of the present invention.

[0047] Figure 7 This is the homozygous site sequencing map of the tobacco mutant T1 generation material with amino acid deletions at positions 97-100 obtained by the lead editing technology in Experimental Example 2 of the present invention.

[0048] Figure 8 This is a phenotypic comparison diagram of the tobacco mutant material with amino acid substitutions at positions 97 and 99 obtained by lead editing in Experimental Example 3 of the present invention and the wild-type material inoculated with PVY virus.

[0049] Fig. 9 This is a bar graph of the ELISA data of the tobacco mutant material with amino acid substitutions at positions 97 and 99 obtained by lead editing in Experimental Example 4 of the present invention and the wild-type material after inoculation with PVY virus.

[0050] Fig.10 This is a phenotypic comparison diagram of the tobacco mutant material with amino acids 97-100 deleted obtained by the lead editing of Experimental Example 5 of the present invention and the wild-type material inoculated with PVY virus.

[0051] Fig.11 This is a bar graph of ELISA data of the tobacco mutant material with amino acids 97-100 deleted obtained by lead editing in Experimental Example 6 of the present invention and the wild-type material after inoculation with PVY virus.

[0052] Fig.12 This is a bar graph of the root length of plants of the tobacco mutant material and the wild-type material of Experimental Example 7 of the present invention grown under room temperature and cold stress. DETAILED DESCRIPTION

[0053] The embodiments of the present invention will be described in detail below in conjunction with the experimental examples, but those skilled in the art will appreciate that the following experimental examples are only used to illustrate the present invention and should not be considered to limit the scope of the present invention. If no specific conditions are specified in the experimental examples, the conditions are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be obtained commercially.

[0054] Sources of biological materials

[0055] 1. Experimental Example 1 of the Present Invention The wild-type tobacco material used as the basic material for obtaining mutants is K326, which is a commercial tobacco variety and is commercially available.

[0056] 2. The wild-type tobacco material used in Experimental Examples 3 and 5 of the present invention is K326, which is a commercial tobacco variety and can be purchased commercially.

[0057] The first group of experimental examples, use of the mutation site of the present invention to resist cold stress

[0058] This group of embodiments provides the use of amino acid mutations at positions 97-100 of the eIF4E-1 factor in alleviating the sensitivity of PVY virus-resistant tobacco mutants to cold stress.

[0059] In a specific embodiment, the amino acid mutation at positions 97-100 of the eIF4E-1 factor is selected from: deletion of amino acids at positions 97-100 of the eIF4E-1 factor, and / or substitution of amino acids at positions 97 and 99 of the eIF4E-1 factor;

[0060] Preferably, the amino acid substitutions at positions 97 and 99 refer to: the amino acid Val at position 97 is substituted with Gln, and the amino acid Ala at position 99 is substituted with Glu;

[0061] Preferably, the PVY virus-resistant tobacco mutant refers to tobacco material with eIF4E-1 gene mutation;

[0062] Preferably, the eIF4E-1 gene mutations include: eIF4E-1 gene position 289 G mutation to C, eIF4E-1 gene position 290 T mutation to A, eIF4E-1 gene position 297 C mutation to A;

[0063] Preferably, the chilling stress refers to chilling stress below 8°C.

[0064] Group 2 Examples, Proteins of the Present Invention

[0065] This group of embodiments provides a protein that alleviates the sensitivity of PVY virus-resistant tobacco mutants to chilling stress. This group of embodiments all have the following common features: the protein that alleviates the sensitivity of PVY virus-resistant tobacco mutants to chilling stress is a protein obtained by mutation of amino acids 97-100 of the eIF4E-1 factor.

[0066] In some embodiments, the protein with amino acid mutations at positions 97-100 of the eIF4E-1 factor is selected from: a protein with amino acid deletions at positions 97-100 of the eIF4E-1 factor, and / or a protein with amino acid substitutions at positions 97 and 99 of the eIF4E-1 factor;

[0067] Preferably, the protein in which the amino acids at positions 97 and 99 of the eIF4E-1 factor are replaced refers to a protein in which the amino acid at position 97 Val is replaced by Gln, and the amino acid at position 99 Ala is replaced by Glu;

[0068] Preferably, the protein with amino acids 97-100 deleted from eIF4E-1 factor has the amino acid sequence shown in SEQ ID NO.1;

[0069] MAEEAEKLRVDEVEVVDDGPEEGEIVDESDDTASYLGKEIKPKHPLENSWTFWFDNPMAKSRQAAWGSSLRELYTFSTVEDFWGVYNNINHPSKLVFHCFKHKIEPKWED PVCANGGNWTMSFSKGKSDTSWLYTLLAMIGHQFDHGEEICGAVVSVRNKGDKIALWTKNAANETAQVSIGKQWKEFLDYSNSIGFIFHDDSMRLGRGAKNRYTV(SEQID NO.1).

[0070] Preferably, the protein with amino acids 97 and 99 substituted in the eIF4E-1 factor has the amino acid sequence shown in SEQ ID NO.2.

[0071] MAEEAEKLRVDEVEVVDDGPEEGEIVDESDDTASYLGKEIKPKHPLENSWTFWFDNPMAKSRQAAWGSSLRELYTFSTVEDFWGVYNNINHPSKLVQGEDFHCFKHKIEPK WEDPVCANGGNWTMSFSKGKSDTSWLYTLLAMIGHQFDHGEEICGAVVSVRNKGDKIALWTKNAANETAQVSIGKQWKEFLDYSNSIGFIFHDDSMRLGRGAKNRYTV(SEQ ID NO.2).

[0072] The third group of examples, genes of the present invention

[0073] This group of embodiments provides a gene that alleviates the sensitivity of PVY virus-resistant tobacco mutants to chilling stress. This group of embodiments all have the following common features: the gene that alleviates the sensitivity of PVY virus-resistant tobacco mutants to chilling stress is a gene obtained by mutation of bases 289-300 of the eIF4E-1 gene.

[0074] In some embodiments, the gene obtained by mutation of bases 289-300 of the eIF4E-1 gene is selected from: a gene obtained by deletion of bases 289-300 of the eIF4E-1 gene, and / or a gene obtained by substitution mutation of bases 289-291 and 295-297 of the eIF4E-1 gene;

[0075] Preferably, the gene obtained by base substitution mutations at positions 289-291 and 295-297 of the eIF4E-1 gene refers to a gene obtained by mutation of G at position 289 to C, mutation of T at position 290 to A, and mutation of C at position 297 to A of the eIF4E-1 gene;

[0076] Preferably, the gene obtained by mutation of bases 289-300 of the eIF4E-1 gene has a nucleotide sequence as shown in SEQ ID NO.3;

[0077] ATGGCAGAGGAAGCTGAGAAATTGCGGGTAGATGAAGTAGAAGTAGTCGACGATGGACCTGAAGAAGGAGAAATTGTGGATGAATCTGATGATACGGCGTCGTATTTGGGCAAAGAAATCAAACCTAAGCATCCATTAGAGAATTCTTGGACTTTTTGGTTTGATAATCCTATGGCTAAATCTAGACAAGCTGCTTGGGGCAGTTCCCTTCGCGAACTTTACACTTTTTCCACTGTCGAAGATTTTTGGGGTGTTTACAATAATATCAACCACCCAAGCAAGTTAGTTTTTCATTGTTTTAAGCATAAAATTGAGCCAAAGTGGGAAGATCCTGTATGTGCGAATGGAGGGAATTGGACAATGAGCTTTAGTAAGGGTAAATCTGATACCAGCTGGCTATACACGCTGCTGGCAATGATTGGACATCAATTCGATCATGGAGAGGAAATTTGTGGAGCAGTAGTTAGCGTCCGAAATAAGGGGGATAAAATAGCTTTATGGACCAAGAATGCTGCAAATGAAACAGCTCAGGTTAGCATTGGTAAGCAATGGAAGGAGTTTCTGGATTACAGCAACTCGATTGGCTTCATATTTCATGACGACTCAATGAGGCTCGGCAGAGGTGCCAAGAATCGTTATACAGTATAG(SEQ ID NO.3).

[0078] Preferably, the gene obtained by base substitution mutations at positions 289 - 291 and 295 - 297 of the eIF4E-1 gene has the nucleotide sequence shown in SEQ ID NO.4.

[0079] (SEQ ID NO.4).

[0080] The fourth group of embodiments, the method of the present invention for alleviating the sensitivity of PVY virus-resistant tobacco mutants to chilling stress

[0081] This group of embodiments provides a method for alleviating the sensitivity of PVY virus-resistant tobacco mutants to chilling stress. This group of embodiments all have the following common features: mutating the amino acids at positions 97-100 of the eIF4E-1 factor of wild-type tobacco materials or mutating the bases at positions 289-300 of the eIF4E-1 gene of wild-type tobacco materials.

[0082] In some embodiments, the mutation of amino acids 97-100 of the eIF4E-1 factor of the wild-type tobacco material is selected from: deleting amino acids 97-100 of the eIF4E-1 factor of the wild-type tobacco material, and / or replacing amino acids 97 and 99 of the eIF4E-1 factor of the wild-type tobacco material;

[0083] The mutation of bases 289-300 of the eIF4E-1 gene of the wild-type tobacco material is selected from: deleting bases 289-300 of the eIF4E-1 gene of the wild-type tobacco material, and / or replacing bases 289-291 and 295-297 of the eIF4E-1 gene of the wild-type tobacco material;

[0084] Preferably, the epegRNA sequence in which the amino acids 97-100 of the eIF4E-1 factor of the wild-type tobacco material are deleted or the bases 289-300 of the eIF4E-1 gene of the wild-type tobacco material are deleted is as shown in SEQ ID NO.5;

[0085] Preferably, the epegRNA sequence in which the amino acids 97 and 99 of the eIF4E-1 factor of the wild-type tobacco material are replaced or the bases 289-291 and 295-297 of the eIF4E-1 gene of the wild-type tobacco material are replaced is as shown in SEQ ID NO.6.

[0086] The fifth group of embodiments, the method of obtaining and screening tobacco mutants resistant to PVY and insensitive to chilling stress according to the present invention

[0087] This group of embodiments provides a method for obtaining and screening tobacco mutants that are resistant to PVY and insensitive to chilling stress. This group of embodiments all have the following common features: tobacco mutants that are resistant to PVY and insensitive to chilling stress are obtained by using a method for alleviating the sensitivity of tobacco mutants resistant to PVY virus to chilling stress as described in any one of the fourth group of embodiments.

[0088] In a specific embodiment, the screening refers to: using VGAD-F3 and VGAD-R3 primers to perform DNA amplification and sequencing on candidate tobacco materials.

[0089] Experimental Example 1: Obtaining tobacco mutant materials

[0090] To develop primary editors in tobacco, we used the AtU6 promoter to express epegRNA with evoPreQ1. The PE protein was inserted between the 2x35S promoter and the NOS terminator. Arabidopsis thaliana ath-MIR390a (pre-miR390a) was used to express artificial miRNAs in tobacco, and amiRNAs targeting NtMSH2 were designed as described. The coding sequence of the dominant negative form of NtPMS1 (1–139 amino acids) was synthesized by Qingke (Shanghai, China). In DiPE2, amiRNAs targeting NtMSH2 were used to block the MMR pathway. To express dominant negative NtPMS1 and amiRNtMSH2 simultaneously in DiPE2, we used an intronic amiRNA generation strategy. The amiRNtMSH2 pre-miRNA was inserted into the potato (Solanum tuberosum) IV2 intron, which was then inserted into NtPMS1 (1–417 nucleotides). These MMR repressor elements were expressed under the control of the 2x35S promoter. They were assembled into the pCambia1300 binary vector along with the epegRNA and PE protein expression cassettes. pegRNA or epegRNA was assembled by overlapping PCR and ligated into the prime editor via Golden Gate.

[0091] The epegRNA sequence of the 97-100 deletion plant used in this experimental example is cacccaagcaagttagttgtgttttagagctagaaatagcaagttaaaataaggctagtccgttatcaacttgaaaaagtggc accgagtcggtgcacaatgaaaaactaacttgcttggg (SEQ ID NO. 5).

[0092] The epegRNA sequence used in the plants with amino acid substitutions at positions 97 and 99 is cacccaagcaagttagttgtgttttagagctagaaatagcaagttaaaataaggctagtccgttatcaacttgaaaaagtggc accgagtcggtgcagtcttctccctgaactaacttgcttggg (SEQ ID NO.6).

[0093] The prime editing method was used to obtain tobacco mutant materials with amino acid substitutions at positions 97 and 99 and tobacco mutant materials with amino acid deletions at positions 97-100. The edited fragments were connected to the DiPE2 vector ( Figure 1The recombinant plasmid DiPE2 was transformed into Agrobacterium LBA4404 by freeze-thaw method, the positive Agrobacterium strains were identified by colony PCR, and the tobacco variety K326 was transformed by Agrobacterium-mediated leaf disc method.

[0094] The specific method is as follows:

[0095] (1) Under sterile conditions, place tobacco seeds in an EP tube and rinse with sterile water 2-3 times;

[0096] (2) Soak in 75% alcohol for 30-60 seconds;

[0097] (3) Treat with 0.1% mercuric chloride for 5 min, and finally rinse with sterile water 5 times;

[0098] (4) Sow on MS medium and culture in the tissue culture room of Yunnan Tobacco Agricultural Science Research Institute in the dark for 4 days and in the light at 25°C for 20-30 days.

[0099] (5) When the tobacco seedlings grow to 3-5 cm (20-30 days), take the top buds and place them on MS+BA0.2 mg / L (to strengthen the buds and make them grow quickly) culture medium for subculture.

[0100] (6) After 14 days of subculture (small leaves are sufficient), take leaves of 1 cm x 1 cm in size, cut off the petiole, scratch the leaf surface and leaf edge, and place them on the pre-culture medium of MS + BA 1.0 mg / L pH 6.0-6.5, with the front side facing down and close to the culture medium, and pre-culture in the dark for 2-3 days.

[0101] (7) Then take out the pre-cultured leaves or stem segments and place them in the infection solution for infection. The night before infection, shake 2 bottles of Agrobacterium. Fill a 2ml centrifuge tube with the bacterial solution, centrifuge at 4000rpm for 5 minutes, and wash twice with the bacterial suspension. Add the bacterial suspension at a ratio of 1:10 (10ml of the bacterial suspension to 1 tube of 1.5ml bacteria), add As25 mg / L (40ulAs in 40ml), and shake the infection solution continuously to make it fully contact with the cut of the leaves and stem segments. After 10 minutes, take it out and place it on a sterilized dry filter paper to absorb the bacterial solution;

[0102] (8) Place the leaves and stem segments back on the pre-culture medium and culture them in the dark at 28°C for 2-3 days until microplaques form around the leaf cuts;

[0103] (9) Washing the bacteria: Take out the co-cultured tobacco leaves and stems, rinse them five times with sterile water supplemented with 500 mg / L Cef, and shake them on a shaker for 30 min the first time and for 5 min each time thereafter to wash away the Agrobacterium on the surface of the explants;

[0104] (10) After taking out, blot dry with filter paper and transfer to tobacco budding medium, which is MS + BA 1.0 mg / L + Hyg 25 mg / L + Cef 500 mg / L pH 5.8; observe after 2 weeks. If no bacteria grow, reduce the Cef concentration. If bacteria grow, continue to maintain the Cef concentration.

[0105] (11) Replace the culture medium every two weeks until adventitious buds grow (usually 2 weeks). Cut off the regenerated seedlings (about 1 cm) and transfer them to the subculture medium MS + BA 0.2-0.1 mg / L + Hyg 25 mg / L + Cef 500 mg / L pH 5.8;

[0106] (12) When the seedlings grow to 2 cm in length (with small buds), transfer them to rooting medium MS + NAA 0.2-0.1 mg / L and culture them at 24 ± 1°C, 12 h light, 1500 lx for about three weeks to grow strong roots.

[0107] (13) When the roots grow to 2-3 cm and the seedlings are about 7-10 cm tall, remove the flask, wash off the root culture medium, transplant into a flower pot, and culture in the greenhouse.

[0108] Experimental Example 2: Detection of tobacco mutant material fragments obtained using lead editing technology

[0109] According to the sequence of tobacco eIF4e1 gene in NCBI (NCBI: LOC104219085), NEB Phusion Q5 high-fidelity enzyme was used to amplify the target fragment. VGAD-F3GAGTCCGCGCAACTTAGGAT and VGAD-R3ATCCCCCTTATTTCGGACGC were used to amplify the target fragment.

[0110] The amplification system and procedures are as follows:

[0111]

[0112] The electrophoresis results obtained by amplifying the tobacco mutant material with amino acid substitutions at positions 97 and 99 are as follows Figure 2 The PCR product was sent to a sequencing company for sequencing, and it was found that the bases corresponding to GT-C of tobacco Val97 and Ala99 amino acids had mutated, and Gln97 and Glu99 were in a heterozygous state ( Figure 4 ). Tobacco plants with heterozygous mutations were selected, their seeds were harvested, and they were sown again. After that, the mutant materials were tested again according to the scheme in Experimental Example 2 (the results are shown in FIG. Figure 5 From these, homozygous plants were selected for disease resistance testing.

[0113] The electrophoresis results obtained by amplifying the tobacco mutant material with amino acid deletion at positions 97-100 are as follows Figure 3 The PCR product was sent to a sequencing company for sequencing, and it was found that the bases in the GTGGGAGCAGAC interval corresponding to the amino acid Val97Gly98Ala99Asp100 of tobacco had mutated, showing a heterozygous state ( Figure 6 ). Tobacco plants with heterozygous mutations were selected, their seeds were harvested, and they were sown again. After that, the mutant materials were tested again according to the scheme in Experimental Example 2 (the results are shown in FIG. Figure 7 From these, homozygous plants were selected for disease resistance testing.

[0114] Experimental Example 3: Disease resistance phenotype of tobacco mutant material with amino acid substitutions at positions 97 and 99

[0115] Sterilize the grinding dish, grinding rod, and SiO2 (powder) in advance, prepare PBS buffer solution Ph=7.0 (prepare as needed), weigh the leaves containing only PVY virus, and record the weight (g). Put the leaves in the grinding dish and pour liquid nitrogen into the grinding until powder. Pour PBS buffer solution, the buffer volume: leaf weight is 50:1, mix well, (due to the presence of liquid nitrogen, some crushed ice will appear, just let it sit for a few minutes). Seedling age: 4 leaves per core. Before inoculation, you need to take a small amount of leaves with PVY virus in advance and use a test paper to test whether it only contains PVY. If the number of inoculated plants is small, you can use the manual inoculation method. Select two leaves from each plant and sprinkle SiO2 on the leaves. Use your hands to dip the prepared PVY virus liquid and gently rub it on the leaves, or use a brush to dip the virus liquid and gently brush it on the leaves. If the number of inoculated plants is large, you can use the spraying method. Add the prepared virus liquid to the spray gun connected to the air pump and sprinkle it directly on the leaves.

[0116] Environmental temperature: Keep the temperature at 28℃ and the humidity at 60%. The disease will occur in 7-10 days. The experimental results show that the bases of Val97 and Ala99 amino acids corresponding to GT-C have mutated to Gln97 and Glu99. Compared with the wild-type plants, after inoculation with PVY virus, the plants show obvious disease resistance ( Figure 8 ).

[0117] Experimental Example 4: Virus detection of tobacco mutant materials with amino acid substitutions at positions 97 and 99

[0118] Take the mutant material and control material inoculated with PVY virus for ELISA detection. The experimental process is as follows. Coating: Prepare the ELISA plate, prepare the carbonate coating solution and add the PVY coating antibody (Capture antibody) (1:200), mix the corresponding antibody and add it to the well, 100ul per well, incubate at 4℃ overnight. Grind the sample thoroughly, add 1ml GEB solution to fully dissolve and shake for 2-3min, centrifuge at 12000rpm for 8min. Wash the coated ELISA plate, add 100ul sample protein crude extract per well, repeat 3 times for each sample, and incubate at 37℃ for 2 hours. Prepare ECI Buffer, (PVY-Alkphos enzyme, PVY-Detection antibody), 1:200, add the required amount. Wash the plate, add the ECI and antibody prepared in step 5 after washing, add 100ul per well, incubate at 37℃ for 2h, and then wash the plate. Prepare PNP+PNP Buffer PNP Buffer 5X 2ml+9ml (sterile water)+2 PNP pellets (the amount for one plate) and add 100ul to each well. Develop color in the dark (first leave it for 15 minutes to observe the color development, and leave it for a while longer if it is not obvious), read the OD405 value after 45 minutes, and take a photo to save the results of the ELISA plate.

[0119] The results showed that the bases corresponding to GT-C in Val97 and Ala99 amino acids had mutated to Gln97 and Glu99. After inoculation with PVY virus, the ELISA values ​​were significantly lower than those of the wild type ( Fig. 9 ), which shows that knocking out these four amino acids in tobacco can significantly improve resistance to PVY virus.

[0120] Experimental Example 5: Phenotype of tobacco mutant material with amino acid deletion at positions 97-100

[0121] Sterilize the grinding dish, grinding rod, and SiO2 (powder) in advance, prepare PBS buffer solution Ph=7.0 (prepare as needed), weigh the leaves containing only PVY virus, and record the weight (g). Put the leaves in the grinding dish and pour liquid nitrogen into the grinding until powder. Pour PBS buffer solution, the buffer volume: leaf weight is 50:1, mix well, (due to the presence of liquid nitrogen, some crushed ice will appear, just let it sit for a few minutes). Seedling age: 4 leaves per core. Before inoculation, you need to take a small amount of leaves with PVY virus in advance and use a test paper to test whether it only contains PVY. If the number of inoculated plants is small, you can use the manual inoculation method. Select two leaves from each plant and sprinkle SiO2 on the leaves. Use your hands to dip the prepared PVY virus liquid and gently rub it on the leaves, or use a brush to dip the virus liquid and gently brush it on the leaves. If the number of inoculated plants is large, you can use the spraying method. Add the prepared virus liquid to the spray gun connected to the air pump and sprinkle it directly on the leaves.

[0122] Environmental temperature: Maintain the temperature at 28℃ and humidity at 60%. The disease will occur in 7-10 days. Fig.10 As shown, the experimental results showed that after deleting the four amino acids Val97Gly98Ala99Asp100 corresponding to the GTGGGAGCAGAC bases, the plants showed obvious disease resistance after being inoculated with PVY virus compared with the wild-type plants.

[0123] Experimental Example 6: Virus detection of tobacco mutant material with amino acid deletion at positions 97-100

[0124] Take the mutant material and control material inoculated with PVY virus for ELISA detection. The experimental process is as follows. Coating: Prepare the ELISA plate, prepare the carbonate coating solution and add the PVY coating antibody (Capture antibody) (1:200), mix the corresponding antibody and add it to the well, 100ul per well, incubate at 4℃ overnight. Grind the sample thoroughly, add 1ml GEB solution to fully dissolve and shake for 2-3min, centrifuge at 12000rpm for 8min. Wash the coated ELISA plate, add 100ul sample protein crude extract per well, repeat 3 times for each sample, and incubate at 37℃ for 2 hours. Prepare ECI Buffer, (PVY-Alkphos enzyme, PVY-Detection antibody), 1:200, add the required amount. Wash the plate, add the ECI and antibody prepared in step 5 after washing, add 100ul per well, incubate at 37℃ for 2h, and then wash the plate. Prepare PNP+PNP Buffer PNP Buffer 5X 2ml+9ml (sterile water)+2 PNP pellets (amount for one plate) and add 100ul to each well. Color development in the dark (first leave it for 15 minutes to observe the color development, if it is not obvious, leave it for a while longer), read the OD405 value after 45 minutes, take a photo and save the results of the ELISA plate. Fig.11 As shown, the results showed that after the four amino acids Val97Gly98Ala99Asp100 corresponding to the GTGGGAGCAGAC base deletion were inoculated with PVY virus, the ELISA value was significantly lower than that of the wild type, which indicates that knocking out these four amino acids in tobacco can significantly improve resistance to PVY virus.

[0125] Experimental Example 7: Cold resistance test of tobacco mutant material with amino acid deletion at positions 97-100

[0126] The mutant seeds and wild-type seeds of Experimental Example 3, Experimental Example 5, or Experimental Example 6 were sterilized with 5% sodium hypochlorite and then spotted on the culture medium. After the seeds germinated for 7 days, the plants were moved to the vertical culture medium plate for culture. After the plants grew on the vertical plate for 14 days, the vertical plate was moved to an 8°C incubator for culture for 14 days. The results are as follows Fig.12As shown, it can be observed that the growth of mutant plants is significantly better than that of wild-type plants, proving that mutant plants can increase the plant's resistance to cold damage.

Claims

1. Use of the amino acid mutations at positions 97-100 of the eIF4E-1 factor in alleviating the sensitivity of PVY virus-resistant tobacco mutants to cold stress.

2. The use of the amino acid mutations at positions 97-100 of the eIF4E-1 factor according to claim 1 in alleviating the sensitivity of PVY virus-resistant tobacco mutants to chilling stress, characterized in that: The amino acid mutation at positions 97-100 of the eIF4E-1 factor is selected from: deletion of amino acids at positions 97-100 of the eIF4E-1 factor, and / or substitution of amino acids at positions 97 and 99 of the eIF4E-1 factor; And / or, the amino acid substitutions at positions 97 and 99 refer to: the amino acid Val at position 97 is substituted with Gln, and the amino acid Ala at position 99 is substituted with Glu; And / or, the PVY virus-resistant tobacco mutant refers to tobacco material with eIF4E-1 gene mutation; and / or, the eIF4E-1 gene mutations include: mutation of G to C at position 289 of the eIF4E-1 gene, mutation of T to A at position 290 of the eIF4E-1 gene, and mutation of C to A at position 297 of the eIF4E-1 gene; And / or, the chilling stress refers to chilling stress below 8°C.

3. A protein that alleviates the sensitivity of PVY virus-resistant tobacco mutants to cold stress, characterized in that: It is a protein obtained by mutation of amino acids 97-100 of eIF4E-1 factor.

4. The protein for alleviating the sensitivity of PVY virus-resistant tobacco mutants to chilling stress according to claim 3, characterized in that: The protein with amino acid mutations at positions 97-100 of the eIF4E-1 factor is selected from: a protein with amino acids at positions 97-100 deleted from the eIF4E-1 factor, and / or a protein with amino acids at positions 97 and 99 replaced from the eIF4E-1 factor; and / or, the protein in which the amino acids at positions 97 and 99 of the eIF4E-1 factor are substituted refers to a protein in which the amino acid at position 97 Val is substituted with Gln, and the amino acid at position 99 Ala is substituted with Glu; and / or, the protein in which amino acids 97-100 of the eIF4E-1 factor are deleted has the amino acid sequence shown in SEQ ID NO.1; And / or, the protein with amino acids 97 and 99 of eIF4E-1 factor substituted has the amino acid sequence shown in SEQ ID NO.

2.

5. A gene that alleviates the sensitivity of a PVY virus-resistant tobacco mutant to cold stress, characterized in that: This is a gene obtained by mutation of bases 289-300 of the eIF4E-1 gene.

6. A gene for alleviating the sensitivity of a PVY virus-resistant tobacco mutant to chilling stress according to claim 5, characterized in that: The gene obtained by mutation of bases 289-300 of the eIF4E-1 gene is selected from: a gene obtained by deletion of bases 289-300 of the eIF4E-1 gene, and / or a gene obtained by substitution mutation of bases 289-291 and 295-297 of the eIF4E-1 gene; And / or, the gene obtained by base substitution mutations at positions 289-291 and 295-297 of the eIF4E-1 gene refers to a gene obtained by mutation of G at position 289 to C, mutation of T at position 290 to A, and mutation of C at position 297 to A of the eIF4E-1 gene; and / or, the gene obtained by mutation of bases 289-300 of the eIF4E-1 gene has a nucleotide sequence as shown in SEQ ID NO.3; And / or, the gene obtained by base substitution mutation at positions 289-291 and 295-297 of the eIF4E-1 gene has a nucleotide sequence as shown in SEQ ID NO.

4.

7. A method for alleviating the sensitivity of PVY virus-resistant tobacco mutants to chilling stress, characterized in that: The amino acids at positions 97-100 of the eIF4E-1 factor of the wild-type tobacco material are mutated, or the bases at positions 289-300 of the eIF4E-1 gene of the wild-type tobacco material are mutated.

8. The method for alleviating the sensitivity of PVY virus-resistant tobacco mutants to chilling stress according to claim 7, characterized in that: The mutation of amino acids 97-100 of the eIF4E-1 factor of the wild-type tobacco material is selected from: deleting amino acids 97-100 of the eIF4E-1 factor of the wild-type tobacco material, and / or replacing amino acids 97 and 99 of the eIF4E-1 factor of the wild-type tobacco material; The mutation of bases 289-300 of the eIF4E-1 gene of the wild-type tobacco material is selected from: deleting bases 289-300 of the eIF4E-1 gene of the wild-type tobacco material, and / or replacing bases 289-291 and 295-297 of the eIF4E-1 gene of the wild-type tobacco material; And / or, the epegRNA sequence obtained by deleting amino acids 97-100 of the eIF4E-1 factor of the wild-type tobacco material or deleting bases 289-300 of the eIF4E-1 gene of the wild-type tobacco material is as shown in SEQ ID NO.5; And / or, the epegRNA sequence obtained by replacing amino acids 97 and 99 of the eIF4E-1 factor of the wild-type tobacco material or replacing bases 289-291 and 295-297 of the eIF4E-1 gene of the wild-type tobacco material is as shown in SEQ ID NO.

6.

9. A method for obtaining and screening tobacco mutants that are resistant to PVY and insensitive to chilling stress, characterized in that: A tobacco mutant that is resistant to PVY and insensitive to chilling stress is obtained by using the method for alleviating the sensitivity of a PVY virus-resistant tobacco mutant to chilling stress as described in claim 7 or 8.

10. The method for obtaining and screening tobacco mutants resistant to PVY and insensitive to chilling stress according to claim 9, characterized in that: The screening refers to: using VGAD-F3 and VGAD-R3 primers to amplify and sequence DNA of candidate tobacco materials.

Citation Information

Cited By

  • Plant antivirus-related miR159a and application thereof in improving virus resistance of plants

    CN120648688A